innovative platform technology

Innovative Technology Platform

Entera's innovative technology enables oral drug delivery of large molecules

27163516 pills

Pipeline of Drug Development

Entera conducts clinical trials of three oral drugs based on a proven active compound

27163516 brain green

Experienced Management Team

The managers of Entera have more than 50 years of experience in drug development

August 25, 2013 - Phase I clinical trials of Entera's oral drug for osteoporosis have been successfully completed. The desirable Cmax - the maximal concentration of the active compound in blood - has been attained with no side effects.